{
"@context": "/terms/",
"@id": "/treatments/34f4d2ee-1328-4685-957d-a353d8e90360/",
"@type": [
"Treatment",
"Item"
],
"aliases": [
"hao-wu:IWP2_day3"
],
"amount": 2.5,
"amount_units": "μM",
"audit": {},
"award": {
"@id": "/awards/HG012012/",
"component": "data coordination"
},
"biosamples_treated": [],
"creation_timestamp": "2023-07-05T22:56:02.294523+00:00",
"depletion": false,
"lab": {
"@id": "/labs/j-michael-cherry/",
"title": "J. Michael Cherry, Stanford"
},
"notes": "This treatment does not have award, lab, depletion specified previously, it was upgraded to have Cherry lab/award and depletion=False.",
"purpose": "differentiation",
"release_timestamp": "2023-07-06T18:16:16.736372+00:00",
"schema_version": "9",
"status": "released",
"submitted_by": {
"@id": "/users/43f2f757-5cbf-490a-9787-a1ee85a4cdcd/",
"title": "Jennifer Jou"
},
"summary": "Treatment of 2.5 μM N-(6-methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide",
"treatment_term_id": "CHEBI:125649",
"treatment_term_name": "N-(6-methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide",
"treatment_type": "chemical",
"uuid": "34f4d2ee-1328-4685-957d-a353d8e90360"
}